Historical record - last NADAC effective date: 10/23/2019
Product Information
CALCITRENE 0.005% OINTMENT is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $2.7700 per GM under NDC 51672527803. Its NADAC has been published 310 times since Nov 28, 2013.
FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.05 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672527803
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
10/23/2019
Active Ingredients
CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA090633FDA Approved
3/24/2010
TE Code
AB
On Market Since
3/24/2010
Pharmacological Classes
Price Statistics
The NADAC for CALCITRENE 0.005% OINTMENT has been published 310 times since Nov 28, 2013, and over the history we have for it it has declined 40.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7700 per GM |
|---|---|
| All-time high | $4.6426 (Apr 15, 2015) |
| All-time low | $2.1202 (Nov 21, 2018) |
| Median price | $3.5655 |
| Average price | $3.5013 |
| Largest weekly change | +25.7% (May 22, 2019) |
| Weeks tracked | 310 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-40.2%
Last surveyed Oct 30, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcipotriene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin D Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCITRENE 0.005% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CALCITRENE 0.005% OINTMENT, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $2.7700 per GM (NDC 51672527803), effective Oct 30, 2019.
How has the price of CALCITRENE 0.005% OINTMENT changed over time?
Over the history we have for it, the NADAC for CALCITRENE 0.005% OINTMENT has declined 40.2%. It has been tracked across 310 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CALCITRENE 0.005% OINTMENT?
Since Nov 28, 2013, the NADAC for CALCITRENE 0.005% OINTMENT has ranged from a low of $2.1202 (Nov 21, 2018) to a high of $4.6426 (Apr 15, 2015), with a median of $3.5655 per GM.
Are there cheaper alternatives to CALCITRENE 0.005% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE 0.005% OINTMENT, is $1.9465 per GM — about 30% below CALCITRENE 0.005% OINTMENT.
Who manufactures CALCITRENE 0.005% OINTMENT?
CALCITRENE 0.005% OINTMENT (NDC 51672527803) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.